<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02644343</url>
  </required_header>
  <id_info>
    <org_study_id>CAM 5650</org_study_id>
    <nct_id>NCT02644343</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Remote Programming of Nucleus Cochlear Implants</brief_title>
  <acronym>TEL</acronym>
  <official_title>Safety and Efficacy of Remote Programming of Nucleus Cochlear Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the safety and efficacy of Nucleus cochlear
      implant programming via telecommunication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cochlear implant recipients will undergo remapping at a location remote from their
      audiologist via telehealth. Audiologists will use an internet meeting platform to remotely
      log into the subject's computer and control the programming software. Remote programming
      sessions will be completed both with and without the assistance of a trained facilitator, and
      speech understanding will be tested in between mapping sessions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">May 17, 2017</completion_date>
  <primary_completion_date type="Actual">May 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Speech Perception on monosyllabic word test, CNC Words</measure>
    <time_frame>2-4 weeks post remote programming session</time_frame>
    <description>Subjects will listen to and repeat monosyllabic words from the Consonant Nucleus Consonant word test (Peterson &amp; Lehiste, 1962) to examine their speech perception abilities after each remote programming session.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Telemedicine</condition>
  <arm_group>
    <arm_group_label>Remote Programming Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo remote programming of Nucleus cochlear implants via Custom Sound software using an online interactive meeting platform.
The intervention is the programming of the cochlear implant, the experimental aspect is the remote delivery method.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Custom Sound</intervention_name>
    <description>Custom Sound is the programming software used to program Nucleus cochlear implants.</description>
    <arm_group_label>Remote Programming Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals aged greater than 12 years that are native English speakers and are
             capable of completing the study evaluation as deemed by their primary audiologist

          -  Unilateral or bilateral cochlear implant recipients of a CI24RE, CI422 or CI500 series
             implant who are in possession of a backup sound processor

          -  A minimum of 12 months' experience with a CP800 or CP900 series sound processor, and
             current MAP programmed within 12 months prior to Visit 1

          -  Willingness to participate in and to comply with all requirements of the protocol

          -  Able to demonstrate protocol competence as confirmed by primary audiologist

        Exclusion Criteria:

          -  Unrealistic expectations on the part of the subject, regarding the possible benefits,
             risks, and limitations of remote service delivery

          -  Unwillingness or inability of the candidate to comply with all investigational
             requirements

          -  Additional handicaps that would prevent or restrict participation in the audiological
             evaluations

          -  Inability to demonstrate basic technological skills for simple computer-based tasks
             and device connecting after training by primary audiologist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rocky Mountain Ear Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gatehouse S, Noble W. The Speech, Spatial and Qualities of Hearing Scale (SSQ). Int J Audiol. 2004 Feb;43(2):85-99.</citation>
    <PMID>15035561</PMID>
  </reference>
  <reference>
    <citation>PETERSON GE, LEHISTE I. Revised CNC lists for auditory tests. J Speech Hear Disord. 1962 Feb;27:62-70.</citation>
    <PMID>14485785</PMID>
  </reference>
  <reference>
    <citation>Wesarg T, Wasowski A, Skarzynski H, Ramos A, Falcon Gonzalez JC, Kyriafinis G, Junge F, Novakovich A, Mauch H, Laszig R. Remote fitting in Nucleus cochlear implant recipients. Acta Otolaryngol. 2010 Dec;130(12):1379-88. doi: 10.3109/00016489.2010.492480. Epub 2010 Jun 30.</citation>
    <PMID>20586675</PMID>
  </reference>
  <reference>
    <citation>McElveen JT Jr, Blackburn EL, Green JD Jr, McLear PW, Thimsen DJ, Wilson BS. Remote programming of cochlear implants: a telecommunications model. Otol Neurotol. 2010 Sep;31(7):1035-40. doi: 10.1097/MAO.0b013e3181d35d87.</citation>
    <PMID>20147864</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2015</study_first_posted>
  <last_update_submitted>January 30, 2019</last_update_submitted>
  <last_update_submitted_qc>January 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 4, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT02644343/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 3, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT02644343/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

